Literature DB >> 18462120

Estimating the burden of global mortality in children aged <5 years by pathogen-specific causes.

Salenna R Elliott, James G Beeson.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18462120     DOI： 10.1086/588049

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  13 in total

1.  Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.

Authors:  Michelle J Boyle; Danny W Wilson; Jack S Richards; David T Riglar; Kevin K A Tetteh; David J Conway; Stuart A Ralph; Jake Baum; James G Beeson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

2.  Validation and Application of a Dried Blood Spot Ceftriaxone Assay.

Authors:  Madhu Page-Sharp; Troy Nunn; Sam Salman; Brioni R Moore; Kevin T Batty; Timothy M E Davis; Laurens Manning
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

3.  Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays.

Authors:  Danny W Wilson; Brendan S Crabb; James G Beeson
Journal:  Malar J       Date:  2010-06-03       Impact factor: 2.979

4.  Validation of a Dried Blood Spot Ceftriaxone Assay in Papua New Guinean Children with Severe Bacterial Infections.

Authors:  Mispah Mukap; Corin Sprod; Nakapi Tefuarani; Moses Laman; Madhu Page-Sharp; Sam Salman; Brioni R Moore; Kevin T Batty; Timothy M E Davis; Laurens Manning
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

5.  Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.

Authors:  Jo-Anne Chan; Katherine B Howell; Linda Reiling; Ricardo Ataide; Claire L Mackintosh; Freya J I Fowkes; Michaela Petter; Joanne M Chesson; Christine Langer; George M Warimwe; Michael F Duffy; Stephen J Rogerson; Peter C Bull; Alan F Cowman; Kevin Marsh; James G Beeson
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

6.  The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.

Authors:  Linda Reiling; Jack S Richards; Freya J I Fowkes; Danny W Wilson; Watcharee Chokejindachai; Alyssa E Barry; Wai-Hong Tham; Janine Stubbs; Christine Langer; John Donelson; Pascal Michon; Livingstone Tavul; Brendan S Crabb; Peter M Siba; Alan F Cowman; Ivo Mueller; James G Beeson
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

7.  Intermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and delivery.

Authors:  James G Beeson; Stephen J Rogerson; Ivo Mueller; Jack S Richards; Freya J I Fowkes
Journal:  PLoS Med       Date:  2011-02-01       Impact factor: 11.069

8.  Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.

Authors:  Danny W Wilson; Freya J I Fowkes; Paul R Gilson; Salenna R Elliott; Livingstone Tavul; Pascal Michon; Elija Dabod; Peter M Siba; Ivo Mueller; Brendan S Crabb; James G Beeson
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

9.  Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.

Authors:  Fiona J McCallum; Kristina E M Persson; Cleopatra K Mugyenyi; Freya J I Fowkes; Julie A Simpson; Jack S Richards; Thomas N Williams; Kevin Marsh; James G Beeson
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

Review 10.  Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.

Authors:  Jo-Anne Chan; Freya J I Fowkes; James G Beeson
Journal:  Cell Mol Life Sci       Date:  2014-04-02       Impact factor: 9.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.